Abstract:The interaction of a photoactivatable diazidodihydroxido Pt(IV) prodrug, trans,trans,trans -[Pt(N 3 ) 2 (OH) 2 (py) 2 ] (py = pyridine; 1 ), with a hexamer straight human telomeric DNA unit sequence (5′-T 1 T 2 A 3 G 4 G 5 G 6 -3′, I ) upon light irradiation was investigated by electrospray ionization mass spectroscopy (ESI-MS). In the primary mass spectrum, there were two major mono-platinated I adducts with the bound Pt moieties as trans -[Pt II (N 3 )(py) 2 ] + ( 1′ ) and trans -[Pt II (py) 2 ] 2+ ( 1′′ ), respectively, detected. It is rare to observe such high abundance and nearly equal intensity of platinated DNA adducts formed by these two Pt II species, because 1′ was usually the only major reduced Pt(II) species produced by the photodecomposition of complex 1 in the presence of DNA while 1′′ was rarely detected as major reduced PtII species reported previously. Following tandem mass spectrometric analysis by collision induced dissociation (CID) showed that in the former adduct { I + 1′ } 2+ , G 6 and A 3 were the platination sites. While in the latter adduct { I + 1′′ } 2+ , a potential intrastrand crosslink was speculated after G 4 and G 6 sites were identified. Additionally, other minor platinated adducts like di-platinated I adduct by 1′ with platination sites at G 4 and G 6 and mono-platinated I adducts containing base oxidation were also detected by mass spectrometry. Due to the rich guanines and its sensitivity to oxidation, the oxidation induced by 1 most possibly occurred at guanine. The oxidation adducts were proposed as 8-hydroxyl guanine, spiroiminodihydantoin (Sp), 2,6-diamino-4-hydroxy-5-formamidopyrimidine (FapyG), 5-guanidinohydantoin (Gh) and/or dehydroguanidinohydantoin (DGh) referred to previous reports. The obtained results provide useful chemical information about the photoreaction between photoactivatable Pt(IV) anticancer prodrugs and human telomeric DNA. Such special damages of Pt(IV) prodrugs on human telomeric DNA implicate a role of it in the action of mechanism of the Pt(IV) prodrugs and further support the unique sequence-dependent photointeraction profile of complex 1 reacting with DNA.

Dopamine Oxidation Promoted by Human Telomeric DNA Models in the Presence of a Cu(II) Terpyridine Chelate.

Electrochemical Detection of the Oxidative Damage of a Potential Pyrimido[5,4-G]pteridine-derived Antitumor Agent Toward DNA.

Rational Design and Synthesis of Triazene-Amonafide Derivatives As Novel Potential Antitumor Agents Causing Oxidative Damage Towards DNA Through Intercalation Mode

Terpyridine-Cu(ii) targeting human telomeric DNA to produce highly stereospecific G-quadruplex DNA metalloenzyme.

DNA Damage Induced by Resveratrol and Its Synthetic Analogues in the Presence of Cu (II) Ions: Mechanism and Structure-Activity Relationship.

Oxidation of DNA, proteins and lipids by DOPA, protein-bound DOPA, and related catechol(amine)s

Reaction of human telomeric unit TTAGGG and a photoactivatable Pt(IV) anticancer prodrug

Probing the microscopic structure and flexibility of oxidized DNA by molecular simulations

Human Telomeric Dna Sequences Have A Peroxidase Apoenzyme Activity

Redox-mediated Regulation of an Evolutionarily Conserved Cross-Β Structure Formed by the TDP43 Low Complexity Domain.

Oxidative DNA Damage and Telomeres Shortening

Higher-order Human Telomeric G-quadruplex DNA Metalloenzymes Enhance Enantioselectivity in the Diels-Alder Reaction.

Fluorescence Spectroscopic Insight into the Supramolecular Interactions in DNA-Based Enantioselective Sulfoxidation

Cationic Porphyrin-Mediated G-Quadruplex DNA Oxidative Damage: Regulated by the Initial Interplay between DNA and TMPyP4

DNA oxidation mediated by [Ru(bpy) 2tatp] 2+ upon incorporation of [Co(phen) 3] 3+

Oxidative Dna Cleavage Promoted by Multinuclear Copper Complexes: Activity Dependence on the Complex Structure

The Interaction of DNA with Dopamine by Spectroscopic and Electrochemical Methods

Light-induced oxidation of the telomeric G4 DNA in complex with Zn(II) tetracarboxymethyl porphyrin

A DNA damage-amplifying nanoagent for cancer treatment via two-way regulation of redox dyshomeostasis and downregulation of tetrahydrofolate

Mechanisms of telomerase inhibition by oxidized and therapeutic dNTPs

Inhibition of the Fe(III)-catalyzed dopamine oxidation by ATP and its relevance to oxidative stress in Parkinson's disease.